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Similar effects of ethanol and flumazenil on acquisition of a
shuttle-box avoidance response during withdrawal from chronic
ethanol treatment
'Hugh E. Criswell & George R. Breese
Brain and Development Research Center and Center for Alcohol Studies, University of North Carolina School of Medicine,
Chapel Hill, North Carolina 27599-7250, U.S.A.
1 Acquisition of a two-way shuttle-box avoidance response is facilitated by ethanol. This facilitated
acquisition of an avoidance response to ethanol was attenuated during withdrawal from chronic-ethanol
diet intake (i.e. tolerance developed by ethanol). The deficit in the avoidance task after chronic ethanol
treatment could be overcome by increasing the dose of ethanol.
2 Flumazenil, a benzodiazepine antagonist, also facilitated acquisition of the avoidance response in
control rats. This response to flumazenil was significantly reduced during withdrawal from chronic-
ethanol treatment. This reduced avoidance responding during withdrawal also could be overcome by
increasing the dose of flumazenil.
3 The benzodiazepine-inverse agonist, RO 15-4513, produced a deficit in avoidance responding that
was antagonized by both ethanol and flumazenil in a dose-related manner.
4 To determine whether flumazenil has the properties of a benzodiazepine agonist, it was established
that, unlike the benzodiazepine chlordiazepoxide, flumazenil did not enhance the ethanol-induced deficit
in the aerial righting reflex. Additionally, flumazenil blocked the action of chlordiazepoxide in this
procedure, consistent with the benzodiazepine antagonist action of flumazenil.
5 Data collected are consistent with the hypothesis that an endogenous substance with the properties
of a benzodiazepine-inverse agonist antagonizes the anticonflict actions of acutely administered ethanol
during withdrawal from chronic-ethanol exposure.
Keywords: Flumazenil; ethanol; chronic ethanol treatment; shuttle-box avoidance; avoidance conflict responding; aerial righting
reflex; anxiogenic; anxiolytic; RO 15-4513; ethanol tolerance
Introduction
In 1980, our laboratory compared the effects of ethanol and
benzodiazepines on performance in various behavioural tasks
and concluded they may share a common mechanism of
action (Frye et al., 1980; Vogel et al., 1980). However,
ethanol does not compete with a benzodiazepine for receptor
binding (Frye et al., 1980; Breese et al., 1983). Several early
studies have indicated that ethanol, like benzodiazepines, has
an anticonflict action (Conger, 1956; Barry et al., 1963;
Mansfield et al., 1977; Vogel et al., 1980). More recently, our
laboratory (Frye et al., 1981; Criswell & Breese, 1989) dem-
onstrated that chlordiazepoxide and ethanol facilitated
acquisition of a shuttle-box avoidance response, a finding
consistent with other studies demonstrating that the two-way
avoidance task may have a conflict component (Gray, 1977;
Fernandez-Teruel et al., 1991a,b). During withdrawal from
chronic-ethanol treatment, acquisition of the avoidence re-
sponse was not facilitated by either ethanol or chlordiaze-
poxide, suggestive that there was cross-tolerance between
these drugs (Criswell & Breese, 1989). This latter observation
provided additional support for the position that ethanol has
actions similar to those of the benzodiazepines but the basis
of the tolerance to the action of chlordiazepoxide and
ethanol in the avoidance task following withdrawal from
chronic-ethanol treatment was unknown.
File et al. (1989) reported that flumazenil, a benzo-
diazepine antagonist, reversed the deficit to ethanol seen in a
conflict procedure in rats withdrawn from chronic ethanol
treatment. Furthermore, in a social interaction test,
flumazenil alone reversed the behavioural response associated
with withdrawal from chronic-ethanol or from chronic-
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benzodiazepine administration (Baldwin & File, 1987; File et
al., 1989; File & Hitchcott, 1990). The effect of flumazenil in
these conflict tasks during withdrawal from ethanol or a
benzodiazepine (File & Hitchcott, 1990) could be explained if
flumazenil had a benzodiazepine agonist action or if it was
antagonizing the effect of an endogenous compound with
benzodiazepine-inverse agonist activity (File et al., 1989; File
& Hitchcott, 1990).
It is not known whether the reduced responding to ethanol
in the avoidance task observed during withdrawal from
chronic-ethanol treatment would be attenuated by flumazenil,
as has been demonstrated in another conflict task (File et al.,
1989). For this reason, the present investigation examined (1)
the effect of the benzodiazepine antagonist, flumazenil, alone
and on the action of an acute dose of ethanol in rats perfor-
ming the avoidance procedure, (2) the effect of varying doses
of flumazenil and ethanol on shuttle-box avoidance responses
following withdrawal from chronic ethanol treatment; (3)
whether a benzodiazepine-inverse agonist would produce a
deficit in the acquisition of the avoidance response; (4) the
action of ethanol and flumazenil on the deficit produced by a
benzodiazepine-inverse agonist in the avoidance task, and (5)
the possibility that the anticonflict action of flumazenil was
due to a benzodiazepine agonist-like action of this drug.
From these data, it could be assessed whether findings were
consistent with the hypothesis of File et al. (1989) that an
endogenous compound with benzodiazepine-inverse agonist
properties is responsible for the deficit in the anticonflict
action of ethanol during withdrawal from chronic-ethanol
treatment (Criswell & Breese, 1989; 1990).
Some of these data were presented in abstract form at the
annual Research Society on Alcoholism meeting (Criswell &
Breese, 1990).
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Methods
Animals
Male Sprague-Dawley rats weighing 250 to 275 g were
obtained from Charles River Laboratories (Raleigh, NC,
U.S.A.). The animals were maintained in our animal facilities
until they reached 350 to 550 g. Rats were in the animal
facility for at least two weeks before being used. The rats
were housed individually with a 12 h light-dark cycle and
allowed free access to food and water or a liquid diet as
described below.
Shuttle-box avoidance task
The functional response measured in this investigation was
the rate of acquisition of a two-way shuttle-box avoidance
procedure, with a tone as the warning stimulus (Criswell &
Breese, 1989). For the experimental procedure, each rat was
allowed a 5 min adaptation period prior to avoidance train-
ing after being placed in a shuttle-box (Lehigh Valley Elec-
tronics). Following this adaptation period, the onset of a
tone signalled the beginning of a 10 s avoidance period dur-
ing which the animals could shuttle to the opposite side of
the cage to avoid a 0.7 m footshock. Failure to respond
within the 10 s period resulted in shock onset. Footshock was
terminated when the animals moved to the far side of the
cage (escaped) or at the end of a 5 s period. Avoidance of the
shock or shock termination initiated a 30 s intertrial interval.
Data were collected for 100 trials with the number of
avoidance responses, escapes from shock, crosses during the
intertrial interval, and response omissions (failure to escape
within 5 s) recorded at the end of each 25 trial block for
analysis. During the first few training trials, some rats made
responses during the avoidance period before having received
their first shock; therefore, data were analysed only for the
last 75 trials out of the 100 trial session. Since the avoidance
task does not require food and water deprivation, the
behavioural consequences of chronic exposure to ethanol in a
liquid diet can be assessed (Criswell & Breese, 1989).
In the latter portions of this investigation, we encountered
a shift in the number of untreated rats exhibiting low rates of
avoidance responding during acquisition. Rech (1966) and
Fernandez-Teruel et al. (199la,b) have described such
differences within populations of rats. This has been des-
cribed as a 'batch' effect by File & Hitchcott (1990).
Therefore, we initiated a screening programme as new bat-
ches of rats (n = 36) were acquired from the supplier,
whereby 4 to 6 animals were tested without drug prior to
being assigned to an experiment. Only batches of rats from
which this screen produced a mean of 30 or fewer avoidance
responses during the last 75 trials were used to evalute the
actions of ethanol and flumazenil. A possible 'floor' effect
was avoided with treatments which were expected to produce
a negative action on avoidance responding by choosing bat-
ches of rats with a mean of 45 avoidance responses or greater
during acquisition. Rats with such high response scores were
used to examine the action of a benzodiazepine inverse
agonist, RO-15-4513, in the avoidance task and to evaluate
performance in the avoidance task of a group withdrawn
from chronic ethanol administration. The rats given saline or
liquid diet with each experiment provided a cross-validation
of our original measure of acquisition of the task (i.e. screen)
for appointment to the appropriate experimental protocol.
Aerial righting
The impairment of aerial righting induced by ethanol in the
presence or absence of chlordiazepoxide or flumazenil was
measured by the modified procedure of Leitch et al. (1977)
described by Frye & Breese (1982). The animals were held
upside down by grasping the back of the neck and tail and
dropped onto a soft surface (i.e. a foam rubber pad). Land-
ing on all four feet on two consecutive releases was con-
sidered a successful trial. The distance from the back of the
rat to the foam rubber pad was the measured height. A
control rat is able to demonstrate aerial righting at a height
of approximately 5 cm. Rats treated with ethanol or chlor-
diazepoxide were not released from heights above 50cm.
Drugs and treatments
Ethanol (Aaper Alcohol and Chemical Co., Shelbyville, KY,
U.S.A.) was administered i.p. as a 10% (weight-volume)
solution in saline. This concentration minimizes the irritating
effects of the ethanol. Chlordiazepoxide (Hoffman LaRoche,
Nutley, NJ, U.S.A.) was dissolved in saline and administered
i.p. (I ml kg-' volume). Ethanol was administered chronic-
ally by making a nutritionally complete liquid diet containing
ethanol available to the rats as previously described (Frye et
al., 1981). Control rats received liquid diet with the ethanol
replaced by an equicaloric amount of dextrose. For the
experiments involving 12-day exposure to chronic ethanol, all
animals were habituated to the control liquid diet for 2 days.
On day 3, a diet containing 5% ethanol was substituted for
the control liquid diet in the experimental group. After 2
days, the concentration of ethanol was increased to 7.5% and
2 days later to 10% where it remained for 8 days. Control
animals were limited to 70mlday-' of liquid diet. Animals
drinking the ethanol-liquid diet ingested 1 1.6 ± 0.7 g kg-'
day-'. This diet regimen results in similar weight gains for
the two groups (Frye et al., 1981). Whereas the chronic-
ethanol treated rats exhibit tremors and irritability to hand-
ling, they did not have spontaneous seizures or seizures to
the sound exposure in the avoidance task.
Following chronic exposure of the rats to control liquid
diet or ethanol-containing liquid diet, the diet was removed
and replaced by lab-chow. After 7-9 h of withdrawal from
the ethanol-containing or control-liquid diets, treated and
control rats were given saline or various doses of ethanol, i.p.
This protocol demonstrated tolerance to acute action of
ethanol in the avoidance task in the rats withdrawn from
chronic treatment (Criswell & Breese, 1989). Additional rats
received saline or various doses of flumazenil (RO 15-1788;
Hoffmann-La Roche Pharmaceutical Co., Nutley, NJ. U.S.A.),
either alone or 5 min prior to ethanol. In other experiments
to evaluate the agonist properties of flumazenil, either
flumazenil or chlordiazepoxide (Hoffmann-La Roche Phar-
maceutical Co.) were given alone or in combination with
ethanol and the effect of these drug treatments on aerial
righting was evaluated. The benzodiazepine-inverse agonist
RO-15-4513 (ethyl 8-azido-5,6-dihydro-5 methyl-6-oxo-4H-
imidazo[l,5-a][1,4]benzodiazepinel-3-carboxylate; Hoffmann-La
Roche Pharmaceutical Co.) was suspended in 0.25% carboxyl-
methylcellulose and injected i.p.
Statistics
Total number of avoidance responses, response omissions,
intertrial interval crosses during the last 75 trials of a 100
trial session (see avoidance task) and aerial righting distance
were analysed by ANOVA (Winer, 1962). Individual means
were compared to controls using the Dunnett test (Winer,
1962).
Results
Effects offlumazenil on the response to acutely
administered ethanol in the avoidance task
In agreement with previous work (Frye & Breese, 1981;
Criswell & Breese, 1989), an acute dose of ethanol caused an
increase in avoidance responding in rats treated with control-
liquid diet (Figure 1). Flumazenil pretreatment did not block
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Figure 1 Dose-response effects of ethanol on acquisition of a two-
way shuttle-box avoidance response following withdrawal from cont-
rol or ethanol-liquid diet. The solid column (-) refers to a control
(Con) group which was formed from rats that received ethanol-liquid
diet or control-liquid diet, after it was established that there was no
difference in the responses for these groups (P>0.05); ( 10) refer
to groups of rats that received various doses of acutely administered
ethanol (0.5, 0.75, 1.0 gkg-') during withdrawal from control-liquid
diet; ( q) refer to groups of rats that were tested with various doses
of ethanol (1.0, 1.5, 2.0 gkg-') during withdrawal from ethanol-
containing liquid diet administered for 12 days. Ethanol was
administered 10 min prior to behavioural testing. There were no
differences in the number of response omissions or intertrial crosses
between groups (P>0.1). The mean ± s.e.mean of 5 to 10 rats are
shown for each dose of ethanol. *P<0.05 when compared to saline
control. tP<0.05 when compared to the response to Ig kg-' of
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Figure 2 Effect of increasing doses of flumazenil on acquisition of
an avoidance task in control rats and in rats following withdrawal
from 12 days on an ethanol-liquid diet. Responses to vehicle in rats
that received either control diet or ethanol-liquid diet were not
significantly different (P> 0.05) and were combined (Veh). This
group is designated ( _ ). Other rats that received 12 days of a
control-liquid diet were given various doses of flumazenil (Flu) and
are referred to by ( 1 ). Rats treated for 12 days on an ethanol-
liquid diet and then withdrawn are designated by ( ER. Each dose
of flumazenil or vehicle was administered i.p. 5 min prior to testing.
n for all groups was from 8 to 13, except for the 1 mg kg-' CLD
group (n = 28) and the 10mg kg-' ELD group (n = 6). There were
no differences in response omissions between groups (P> 0.05) and
only the 3 mg kg-' group in the untreated group showed a greater
number of intertrial crosses than did controls (P <0.05). Each value
and bar represent the mean ± s.e.mean. P< 0.05 when compared to
the Veh group. tP< 0.05 when compared to the CLD-Flu 1.0 mg
kg- I group.
Table 1 Effect of flumazenil on the ethanol-induced







Drug doses Avoidance responses












*Flumazenil (Flu; 3 mg kg- ) was administered i.p 5 min
prior to testing. Ethanol (EtOH; 1 g kg-') was administered
10 min prior to testing. No antagonism of the response to
ethanol was observed when the two drugs were
co-administered (Et + Flu; P> 0.1). There were no
differences in response omissions between the groups
(P> 0.05) and only the Et + Flu group showed a greater
number of intertrial crosses than the control group
(P <0.05). n = number. *P< 0.05 when compared to
vehicle control.
the facilitated avoidance responding produced by ethanol
(Table 1), indicating that blockade of benzodiazepine recep-
tors does not affect the ethanol-induced increase in avoidance
responding. However, flumazenil itself produced a significant
increase in avoidance responding (Table 1; Figure 2), demon-
strating that flumazenil induces the same behavioural action
in this task as ethanol and chlordiazepoxide (Criswell &
Breese, 1989). The dose-response effect of flumazenil in the
avoidance task was shallow (Figure 2).
Effect offlumazenil and ethanol in rats withdrawn from
chronic ethanol treatment
Chronic-ethanol treatment for 12 days antagonized the acute
action of ethanol in the avoidance task for doses of ethanol
up to 1.5 g kg-' (Figure 1). A higher dose of ethanol (2 g
kg-') was able to overcome the reduced responses observed
for lower doses of ethanol in the avoidance task during
withdrawal from chronic-ethanol treatment (Figure 1). Addi-
tionally, Figure 2 shows that 12 days on the chronic ethanol-
liquid diet also reduced the usual facilitation of avoidance
responding by 1 mg kg- of flumazenil. As observed when
the dose of ethanol was increased, this reduced effectiveness
of flumazenil during withdrawal was overcome if the dose of
flumazenil was increased to 1Omg kg' (Figure 2).
Effect of the benzodiazepine-inverse agonist RO-15-4513
on avoidance responding and reversal byflumazenil and
ethanol
Various doses of RO-15-4513, a benzodiazepine-inverse
agonist (Mereu et al., 1987; Bonetti et al., 1989; Mehta &
Ticku, 1989) were administered to groups of rats chosen for
their rapid acquisition of this avoidance response (see
Methods). In these rats, RO 15-4513 decreased acquisition of
the avoidance response in a dose-related fashion (Figure 3).
Conversely, the deficit in avoidance responding produced by
RO 15-4513 could be overcome in a dose-related fashion by
flumazenil (Table 2). As expected, ethanol also antagonized
the reduced avoidance responding produced by RO-15-4513
(Figure 4). Due to a probable 'ceiling effect', ethanol and
flumazenil alone had no significant action on avoidance re-
sponding in these rats (P>0.1; data not shown).
However, we did establish that RO 15-4513 induced a
significant deficit in rats with intermediate levels of respond-
ing (data not shown), indicating that this action of RO
15-4513 is not dependent upon the performance level of the
animals.
The effect of ethanol withdrawal on acquisition of
avoidance responding also was examined in a group of rats
selected for rapid acquisition of the avoidance response. A
significant reduction in responding was observed in these rats
during withdrawal from 12 days of chronic-ethanol exposure
(chronic ethanol-liquid diet = 41.0 ± 8.5 avoidance response/
last 75 trials vs control-liquid diet = 63.6 ± 2.8 avoidance
responses/last 75 trials; P<0.05). Thus, a behavioural res-
ponse like that for RO-15-4513 was observed during acute
withdrawal from the chronic-ethanol treatment in these rats
that had high avoidance response scores during acquisition.
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Table 2 Effect of flumazenil (Flu) on the deficit in
acquisition of an avoidance task produced by RO-15-4513




























*Rats were taken from groups shown to aquire a two-way
shuttle box avoidance response (see Methods). Various
doses of flumazenil (Flu, 0.3, 0.6 and 1 mg kg-') were
administered i.p. just prior to rats receiving 1 mg kg-' of
RO-15-4513 (RO) which was 5 min before testing. The dose
of ethanol is 1 g kg-'. There were no differences in response
omissions or intertrial crosses between the group (P<0.1).
'0' under drug doses indicates that no drug was
administered. See Figure 3 for deficit in responding during
acquisition of the avoidance response for RO-15-4513.
n = number.
tP <0.05 when compared to vehicle.
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Figure 3 Dose response curve for the effect of RO 15-4513 on
acquisition of an avoidance task. Naive rats were selected from a
group which had been shown to make a high number of avoidance
responses (see Methods). (0) Is the dose-response curve for RO
15-4513; points show mean ± s.e.mean for 6 rats. The vehicle res-
ponse in the avoidance task is illustrated by the cross-hatched bar
above the curve (vehicle response ± s.e.mean). Vehicle or RO 15-
4513 were injected i.p. 5 min prior to testing. There were no
differences in the number of response omissions or intertrial crosses
between groups (P>0.05). *P<0.05 when compared to vehicle
treatment.
Interactions offlumazenil with ethanol and
chlordiazepoxide on aerial righting
The possibility that flumazenil possessed benzodiazepine
agonist properties was tested by comparing the action of the
benzodiazepine, chlordiazepoxide, to increase ethanol seda-
tion to any change in sedation produced by flumazenil when
combined with ethanol. In accordance with previous studies
(Barthalmus et al., 1978; Okamoto et al., 1985), chlordiaze-
poxide enhanced the ethanol-induced deficit in aerial righting
(Figure 5). Subsequently, it was reasoned that if flumazenil
had a benzodiazepine agonist action, flumazenil, like chlor-
diazepoxide, would enhance the deficit in aerial righting pro-
duced by ethanol. The effects of flumazenil on the deficit in
aerial righting produced by ethanol and chlordiazepoxide are
shown in Figure 6. Flumazenil had no action in this task
either to bloick or augment the action of ethanol (Figure 6).
On the other hand, flumazenil (3 mg kg-') blocked the aerial
righting deficit produced by 10mg kg' of chlordiazepoxide
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Figure 4 Reversal by ethanol of the effect of RO 15-4513 on
performance in the shuttle-box avoidance task. The control group
(no drug) which received only vehicle (Veh) 5 min prior to testing is
designated by ( M ). Various doses of ethanol, ( M ) were
administered 5 min before I mg kg-' of RO 15-4513 to a group of
rats that readily acquired the avoidance response (see Methods).
Testing began 5 min after administration of RO 15-4513
(1.0 mg kg- ). The group designated as the 0.0 dose of ethanol in the
column with cross-hatches received vehicle plus RO-15-4513. There
were no differences in the number of response omissions or intertrial
crosses between the drug-treated and control groups (P>0.05). The
mean ± s.e.mean of 4-6 rats are shown for each dose. Ethanol
(1 g kg-') alone did not produce a significant change from vehicle
(see text). *P <0.05 when compared to vehicle alone (Veh).
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Figure 5 Dose-response relationship for enhancement by chlor-
diazepoxide (CDZ) of the ethanol-induced aerial-righting deficit. (a)
Shows the mean ± s.e.mean of height required for righting for each
10 min period: (0) group that received ethanol alone; (@) group
that received ethanol and I mg kg-' of CDZ; (V) group that
received ethanol plus 3 mg kg-' of CDZ; (V) group that received
ethanol plus 1Omg kg-' of CDZ. Chlordiazepoxide (1, 3 or
10 mg kg-') was administered 5 min prior to ethanol (1.5 g kg-')
administration. Aerial righting was assessed every 10 min for 1 h.
Rats given only saline have scores of approximately 5 cm (Frye &
Breese, 1982), as designated by Pre in (a). The columns in (b) depict
the mean ± s.e.mean score for aerial righting scores for the rats in (a)
for the total time period (1 h): ( L ) group that received only
ethanol; (_) are the three doses of CDZ (1, 3 and 1Omg kg-').
The score for aerial righting observed after 10mgkg-' of chlor-
diazepoxide (CDZ) alone is presented in Figure 6. Each group
consisted of 8 to 12 rats. *P<0.05 when compared to ethanol alone.
increased deficit in aerial righting produced by chlordiaze-
poxide when administered to rats given ethanol (Figure 7).
Thus, flumazenil continued to act as a benzodiazepine
antagonist when given with only chlordiazepoxide as well as
when chlordiazepoxide and ethanol were combined. Conse-
quently, these results provide evidence that flumazenil is not
acting as a benzodiazepine agonist at the doses used in the
avoidance task but acts only as a benzodiazepine antagonist.
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Figure 6 Effect of flumazenil on the aerial-righting deficit induced
by chlordiazepoxide or ethanol. (a) Shows the mean ± s.e.mean
aerial-righting score for 4 groups of 8 rats tested every 10 min for
I h. Flumazenil (Fl, 3 mg kg-') was administered 5 min prior to
either chlordiazepoxide (CDZ; 10mg kg-1) or ethanol (Et,
1.5 g kg-'). Control data (Pre) were obtained immediately prior to
drug administration; and (0) group that received CDZ; (V) refers
to the group that received only ethanol; (@) group that received
CDZ plus flumazenil, and (V) group that received ethanol and
flumazenil. (b) The columns in this panel shown the mean ± s.e.mean
aerial righting score for the accumulated 1 h period for each of the
drug combinations in (a). These groups include CDZ, Et, CDZ + Fl,
and Et + Fl as noted under the columns. Flumazenil alone did not
affect aerial righting in untreated rats (P>0.1). *P<0.05 when
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Figure 7 Effect of flumazenil on the chlordiazepoxide enhancement
of ethanol-induced aerial-righting deficit. (a) Shows the
mean ± s.e.mean aerial righting scores every Omin for rats given
ethanol (Et, 1.5gkg-') 5min after the following treatments were
administered: saline (0, ethanol alone); ethanol plus 10 mg kg-
chlordiazepoxide (@), ethanol plus 3 mg kg' of flumazenil (V) or
ethanol with both flumazenil and chlordiazepoxide (V). Flumazenil
blocked the enhancement of the ethanol-induced aerial-righting
deficit by CDZ for the first 20 min (P <0.05), but did not block the
action of ethanol alone. (b) The columns show mean ± s.e.mean
aerial righting score for the accumulated 1 h test period for each
group in (a); ( ) is for ethanol (Et) alone. The _ are for the
following groups: ethanol plus CDZ (Et + C); ethanol plus
flumazenil (Et + F), and ethanol plus CDZ plus flumazenil (Et +
C + F). Flumazenil alone did not affect aerial righting in untreated
rats (P> 0.1). Eight rats were tested in each group. *P< 0.05 when
compared to ethanol alone.
Discussion
Ethanol can facilitate acquisition of a two-way shuttle-box
avoidance response (Frye & Breese, 1981; Criswell & Breese,
1989). This facilitatory effect of ethanol on avoidance
responding has previously been cited as an indication that
ethanol and chlordiazepoxide exhibit a type of anticonflict
action in this task (Gray, 1977; Criswell & Breese, 1989;
Fernandez-Teruel et al., 1991a,b), similar to that seen in the
acute lick suppression paradigm where shock suppressed lick-
ing is enhanced by these drugs (Vogel et al., 1971; 1980).
While motor stimulants such as (+ )-amphetamine can
facilitate avoidance responding (Rech et al., 1966), the effect
of ethanol in the avoidance task cannot be attributed to
enhanced locomotion, because no dose of ethanol causes an
increased locomotion in our Sprague-Dawley rats (unpub-
lished data; Frye & Breese, 1981; Criswell & Breese, 1989). In
the present work, tolerance to the action of ethanol in
facilitating avoidance responding was observed during with-
drawal from 12 days of chronic-ethanol treatment (i.e. liquid
diet containing ethanol), replicating our previous findings
(Criswell & Breese, 1989). In an earlier study, tolerance to
ethanol during withdrawal from chronic ethanol treatment
was accompanied by cross-tolerance to the action of a benzo-
diazepine in this task (Criswell & Breese, 1989). Tolerance to
the anticonflict action of ethanol during withdrawal from
chronic ethanol treatment also has been reported by File et
al. (1989). Furthermore, an anxiogenic response has been
observed in these behavioural tasks during withdrawal from
chronic administration of both ethanol and benzodiazepines
(Baldwin & File, 1987; File et al., 1989; File & Hitchcott,
1990; Baldwin et al., 1991). This series of studies suggested
that there was a link between the tolerance to the anticonflict
action of ethanol during withdrawal from chronic-ethanol
treatment and benzodiazepine receptor mechanisms.
Flumazenil, a benzodiazepine antagonist, has been reported
to reduce the anxiogenic response associated with withdrawal
from chronic benzodiazepine or ethanol administration
(Baldwin & File, 1987; File et al., 1989; File & Hitchott,
1990), as does ethanol (Figure 2). Nevertheless, unlike a
benzodiazepine or ethanol (Frye et al., 1980; 1983),
flumazenil does not prevent the majority of symptoms
associated with the ethanol-withdrawal syndrome (Little et
al., 1985; Adinoff et al., 1986; Chan et al., 1991). Further-
more, flumazenil did not reduce the acute action of ethanol
in the avoidance task in control rats, indicating that this
action of ethanol was not due to a direct action on ben-
zodiazepine receptors. However, this investigation demon-
strated that flumazenil facilitated acquisition of the avoidance
response in control rats. This behavioural response exhibited
by flumazenil resembled that seen after administration of
ethanol or a benzodiazepine (Criswell & Breese, 1989).
Based on results obtained with flumazenil, File et al. (1989)
proposed the hypothesis that tolerance to the anticonflict
action of ethanol during withdrawal from chronic-ethanol
treatment was related to an increase in an endogenous sub-
stance acting as a benzodiazepine-inverse agonist. Therefore,
one purpose of the present investigation was to determine if
flumazenil would affect tolerance to the anticonflict action of
ethanol in the avoidance task during withdrawal, as had been
noted in another conflict task (File et al., 1989). During
withdrawal from 12 days of chronic-ethanol treatment, the
facilitated responding in the avoidance task following
1 mg kg-' of flumazenil was reduced to levels observed in
rats given vehicle (i.e. tolerance like that observed to ethanol
and chlordiazepoxide after chronic ethanol exposure).
Administration of a higher dose of flumazenil during with-
drawal from chronic ethanol treatment reinstated responding
to a level similar to that observed when a lower dose of
flumazenil was administered to rats receiving control liquid
diet. As noted for flumazenil, increasing the dose of ethanol
also overcame the tolerance observed following withdrawal
from chronic ethanol treatment, providing additional
evidence for similarities between ethanol and flumazenil in
the avoidance task. While metabolic factors could contribute
to the decreased response to ethanol after chronic-ethanol
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planation for the results with flumazenil seems unlikely. Two
additional explanations for these data would be that
flumazenil was antagonizing the action of an endogenous
substance acting as a benzodiazepine-inverse agonist (i.e. as
suggested by File et al., 1989) or that flumazenil was acting
as a benzodiazepine agonist to produce an anticonflict action
in the avoidance task.
With the logic that an endogenous benzodiazepine inverse
agonist might be present during withdrawal, it was reasoned
that, if withdrawal from chronic ethanol was increasing the
presence of an endogenous benzodiazepine-inverse agonist,
then administration of a benzodiazepine-inverse agonist like
RO-15-4513 (Mereu et al., 1987), should produce a deficit in
responding in the avoidance task and this deficit should be
antagonized by flumazenil. In rats chosen for their rapid
acquisition of avoidance responding (see Methods), a dose-
related deficit in acquisition of the avoidance response was
noted after RO-15-4513 administration. This finding is con-
sistent with other reports that benzodiazepine-inverse
agonists produce deficits in behavioural tasks with a conflict
component (Corda et al., 1983; File & Pellow, 1984;
Fernandez-Teruel et al., 1991,a,b; Takada et al., 1992). In
earlier work, File & Lister (1983) reported that the anxio-
genic response to a P-carboline in the social interaction test is
blocked by flumazenil, just as it antagonizes the anticonflict
action of a benzodiazepine (Barrett et al., 1985). Ethanol as
well as flumazenil effectively reversed the deficit in the
avoidance task produced by RO 15-4513. This demonstration
that doses of ethanol or flumazenil could antagonize RO-15-
4513 in the avoidance task would predict that doses of both
ethanol and flumazenil could be found that would produce
an effect in tolerant animals like that seen in control rats.
This in fact was the case. Since RO-15-4513 acts directly on
GABAA receptors, ethanol could be enhancing y-amino-
butyric acid (GABA) responsiveness or acting through a
parallel neural system to overcome the action of RO-15-4513
to reduce responding in the avoidance task. However,
flumazenil reversal of both the effect of RO-15-4513 and the
tolerance to the anticonflict action of ethanol observed in the
avoidance task, seemed most likely to be due to a direct
action on benzodiazepine receptors, an interpretation consis-
tent with the hypothesis proposed by File et al. (1989).
Nonetheless, we next examined the alternative possibility that
flumazenil possessed benzodiazepine agonist activity to pro-
duce behavioural changes in the avoidance task (i.e. was
having an agonist action on benzodiazepine receptors).
The possible agonist activity of flumazenil at the ben-
zodiazepine receptor was supported by in vitro data in which
high concentrations of flumazenil had been reported to pos-
sess a benzodiazepine-like agonist action (Skerritt & Mac-
Donald, 1983; Mehta & Ticku, 1989). However, under most
in vivo conditions, flumazenil has not been reported to exhibit
the pharmacological properties of a benzodiazepine agonist
(Crawley et al., 1984; Barrett et al., 1985; Koob et al., 1986;
Thomas et al., 1990), including a discrimination task for a
benzodiazepine (Pugh, et al., 1992). Such a lack of
behavioural action of flumazenil was observed in the present
investigation when, unlike chlordiazepoxide, it did not affect
the sedation induced by ethanol (i.e. did not affect the deficit
in aerial righting induced by ethanol; Figure 6). Further,
flumazenil not only blocked the deficit produced by chlor-
diazepoxide on aerial righting, but also antagonized the
facilitation of the ethanol-induced aerial righting deficit pro-
duced by chlordiazepoxide. Thus, the present evaluation of
flumazenil in combination with ethanol and chlordiazepoxide
provided convincing evidence that, at doses used in the
avoidance task, flumazenil possesses no discernible ben-
zodiazepine agonist action, but rather is an effective ben-
zodiazepine antagonist. Of course, this absence of an effect of
flumazenil on aerial righting contrasts with the action of
flumazenil to facilitate responding in the avoidance task. File
& Hitchott (1990) as well as Fernandez-Teurel et al.
(199la,b) have implied that the circumstance under which
behavioural measures are taken determine whether flumazenil
will affect behaviour. Our present data are consistent with
this view. Thus, the data collected in the avoidance task and
the lack of evidence that flumazenil acts as a benzodiazepine
agonist are in support of the view that an endogenous
benzodiazepine-inverse agonist could be involved both in the
general poor learning by rats in this behavioural paradigm
(Fernandez-Teurel et al., 1991a,b), as well as in the reduced
anti-conflict action (i.e. tolerance) to ethanol and flumazenil
in the avoidance task during withdrawal from chronic
ethanol treatment (File et al., 1989; File & Hitchcott, 1990).
Schatzkik et al. (1989) has provided evidence for an in-
creased sensitivity of receptors for inverse agonists and
decreased sensitivity of benzodiazepines following withdrawal
from chronic lorazepam treatment. Similarly, Buck & Harris
(1990) provided evidence that chronic ethanol administration
densensitizes benzodiazepine receptors to agonist action while
simultaneously increasing their sensitivity to inverse agonists.
This change in benzodiazepine receptor function would be
expected to produce behavioural changes similar to those
observed in the present study, if a benzodiazepine-inverse
agonist were to be present in brain to influence these sen-
sitized receptors. However, in the latter study, the increase in
sensitivity to a benzodiazepine-inverse agonist was observed
after acute as well as chronic ethanol administration, sugges-
ting that this change in receptor sensitivity is associated with
acute ethanol tachyphylaxis. Tolerance to the effect of
ethanol on shuttle-box avoidance acquisition is not observed
until rats have been treated with ethanol for at least seven
days (Criswell & Breese, 1989).
There have been nunerous attempts to isolate substances
from brain that act on the benzodiazepine receptor (Braest-
rup et al., 1980; Guidotti et al., 1983; Penia et al., 1986). It
seem relatively clear that endogenous benzodiazepines exist
in brain (Sangameswaran et al., 1986; Wolfman et al., 1991).
Likewise, there are endogenous compounds which are pur-
ported to have properties of a benzodiazepine-inverse agonist
(Guidotti et al., 1983; Penia et al., 1986; Novas et al., 1988).
Assuming that these endogenous compounds have an action
in the brain, the absence of an effect of flumazenil in the
aerial righting reflex would relate to a physiological state
where little endogenous benzodiazepine agonist or inverse
agonist were present in brain. Conversely, when rats are
performing the avoidance task during withdrawal from
chronic ethanol (i.e. aversive situation), the content of the
endogenous benzodiazepine-inverse agonist in brain would be
expected to increase to a greater degree than would be
observed under normal conditions. As noted earlier, others
have suggested that the behaviour conditions dictate whether
flumazenil has an effect in a behavioural task (File & Hitch-
cott, 1990; Fernandez-Teurel et al., 1991a,b). In any case, the
similar actions of ethanol and flumazenil, in the absence of
any evidence for a benzodiazepine agonist like action of
flumazenil, provide support for the hypothesis that an
endogenous benzodiazepine-inverse agonist is responsible for
the reduced effectiveness of flumazenil and ethanol in the
avoidance task following withdrawal from chronic-ethanol
treatment (File et al., 1989). The endogenous peptide,
diazepam binding inhibitor (DBI), which was isolated from
mammalian brain (Guidotti et al., 1983), acts as a ben-
zodiazepine inverse agonist (Ferrero et al., 1984; 1986). This
endogenous peptide is reportedly low during normal condi-
tions, but is increased by stressful and anxiety producing
situations (Ferrero et al., 1988; Ferrarese et al., 1991a,b).
Consequently, defining the potential role of this endogenous
peptide in the behavioural change in conflict behaviour in the
avoidance task during withdrawal from chronic ethanol
treatment would be a logical extension of our present inves-
tigation.
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